Home › Funds › TCG Crossover Management, LLC › AMLX

TCG Crossover Management, LLC position in AMLX

AMYLYX PHARMACEUTICALS INC · Health Care

TCG Crossover Management, LLC reported holding 6,243,812 shares of AMLX (AMYLYX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$112.1M, representing 2.70% of its reported portfolio and ranking #10 among its reported holdings. TCG Crossover Management, LLC has disclosed AMLX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)6.24M sh
Reported value held$112.14M
Portfolio Weight2.70%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TCG Crossover Management, LLC's AMLX position evolved

TCG Crossover Management, LLC first disclosed a stake in AMLX in Q3 2024 at 4,643,812 shares (US$15.0M). The position peaked in Q2 2026 at 6,243,812 shares, worth US$112.1M. Across 8 filings, TCG Crossover Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 6,243,812 shares valued at US$112.1M. Notable position changes include a 28% increase in Q1 2025 (shares rose 81% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 4.64M $15.05M New
Q4 2024 4.64M $17.55M Hold
Q1 2025 5.94M $21.04M Add
Q2 2025 5.94M $38.10M Hold
Q3 2025 6.24M $84.85M Add
Q4 2025 6.24M $75.43M Hold
Q1 2026 6.24M $86.79M Hold
Q2 2026 6.24M $112.14M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMLX and 13F data

AMLX (AMYLYX PHARMACEUTICALS INC) is a Health Care company. 50 other funds we track also report a position in AMLX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$149.7M), Commodore Capital LP (US$101.5M), Saturn V Capital Management LP (US$83.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMLX

All AMLX fund holders →

FAQ

How long has TCG Crossover Management, LLC held AMLX?

TCG Crossover Management, LLC has disclosed AMLX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is TCG Crossover Management, LLC's current position in AMLX?

As of Q2 2026, TCG Crossover Management, LLC holds 6.24M shares of AMLX (AMYLYX PHARMACEUTICALS INC), valued at $112.14M, representing 2.70% of its reported portfolio and ranking #10.

Has TCG Crossover Management, LLC been buying or selling AMLX?

In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC held unchanged its position in AMLX. The position peaked in Q2 2026 at 6.24M shares.

Which other funds hold AMLX?

Other major institutional holders of AMLX include PERCEPTIVE ADVISORS LLC, Commodore Capital LP, Saturn V Capital Management LP, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.